Wendy Effah , Marjana Khalil , Dong-Jin Hwang , Duane D. Miller , Ramesh Narayanan
{"title":"在了解雄激素受体的结构和功能以及开发下一代 AR 靶向疗法方面取得进展。","authors":"Wendy Effah , Marjana Khalil , Dong-Jin Hwang , Duane D. Miller , Ramesh Narayanan","doi":"10.1016/j.steroids.2024.109486","DOIUrl":null,"url":null,"abstract":"<div><p>Androgen receptor (AR) and its ligand androgens are important for development and physiology of various tissues. AR and its ligands also play critical role in the development of various diseases, making it a valuable therapeutic target. AR ligands, both agonists and antagonists, are being widely used to treat pathological conditions, including prostate cancer and hypogonadism. Despite AR being studied widely over the last five decades, the last decade has seen striking advances in the knowledge on AR and discoveries that have the potential to translate to the clinic. This review provides an overview of the advances in AR biology, AR molecular mechanisms of action, and next generation molecules that are currently in development. Several of the areas described in the review are just unraveling and the next decade will bring more clarity on these developments that will put AR at the forefront of both basic biology and drug development.</p></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"210 ","pages":"Article 109486"},"PeriodicalIF":2.1000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics\",\"authors\":\"Wendy Effah , Marjana Khalil , Dong-Jin Hwang , Duane D. Miller , Ramesh Narayanan\",\"doi\":\"10.1016/j.steroids.2024.109486\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Androgen receptor (AR) and its ligand androgens are important for development and physiology of various tissues. AR and its ligands also play critical role in the development of various diseases, making it a valuable therapeutic target. AR ligands, both agonists and antagonists, are being widely used to treat pathological conditions, including prostate cancer and hypogonadism. Despite AR being studied widely over the last five decades, the last decade has seen striking advances in the knowledge on AR and discoveries that have the potential to translate to the clinic. This review provides an overview of the advances in AR biology, AR molecular mechanisms of action, and next generation molecules that are currently in development. Several of the areas described in the review are just unraveling and the next decade will bring more clarity on these developments that will put AR at the forefront of both basic biology and drug development.</p></div>\",\"PeriodicalId\":21997,\"journal\":{\"name\":\"Steroids\",\"volume\":\"210 \",\"pages\":\"Article 109486\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Steroids\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0039128X24001247\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Steroids","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0039128X24001247","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
雄激素受体(AR)及其配体雄激素对各种组织的发育和生理非常重要。雄激素受体及其配体在各种疾病的发生发展中也起着关键作用,使其成为有价值的治疗靶点。AR配体(包括激动剂和拮抗剂)正被广泛用于治疗前列腺癌和性腺功能减退症等病症。尽管在过去的五十年中人们对 AR 进行了广泛的研究,但在过去的十年中,人们对 AR 的认识取得了显著的进步,并发现了一些有可能应用于临床的研究成果。本综述概述了 AR 生物学方面的进展、AR 分子作用机制以及目前正在开发的新一代分子。综述中描述的几个领域刚刚揭开神秘面纱,下一个十年将使这些进展更加清晰,从而将 AR 置于基础生物学和药物开发的最前沿。
Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics
Androgen receptor (AR) and its ligand androgens are important for development and physiology of various tissues. AR and its ligands also play critical role in the development of various diseases, making it a valuable therapeutic target. AR ligands, both agonists and antagonists, are being widely used to treat pathological conditions, including prostate cancer and hypogonadism. Despite AR being studied widely over the last five decades, the last decade has seen striking advances in the knowledge on AR and discoveries that have the potential to translate to the clinic. This review provides an overview of the advances in AR biology, AR molecular mechanisms of action, and next generation molecules that are currently in development. Several of the areas described in the review are just unraveling and the next decade will bring more clarity on these developments that will put AR at the forefront of both basic biology and drug development.
期刊介绍:
STEROIDS is an international research journal devoted to studies on all chemical and biological aspects of steroidal moieties. The journal focuses on both experimental and theoretical studies on the biology, chemistry, biosynthesis, metabolism, molecular biology, physiology and pharmacology of steroids and other molecules that target or regulate steroid receptors. Manuscripts presenting clinical research related to steroids, steroid drug development, comparative endocrinology of steroid hormones, investigations on the mechanism of steroid action and steroid chemistry are all appropriate for submission for peer review. STEROIDS publishes both original research and timely reviews. For details concerning the preparation of manuscripts see Instructions to Authors, which is published in each issue of the journal.